Skip to main content

Giraudo Bryan

In the past year, 1 open-market sale filing worth $5.92M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$5.92M
1 filing
Net
−$5.92M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Giraudo Bryan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PTGX Protagonist Therapeutics, Inc

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 11, 2026 (view filing)May 7-84 daysGiraudo BryanDirectorSSale−41.1K$100.12−$4.12M−76.4%12.7K after2 lots
May 11, 2026 (view filing)May 7-84 daysGiraudo BryanDirectorSSale−18.0K$100.05−$1.80M−100.0%0 after2 lots

GOSS Gossamer Bio, Inc.

COO/CFO7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 20, 2024 (view filing)Jun 182 daysGiraudo BryanCOO/CFOPPurchase+100.0K$0.59+$59.0K+26.3%480.0K after
Mar 28, 2024 (view filing)Mar 271 dayGiraudo BryanCOO/CFOSSale−6.43K$1.16−$7.46K−6.5%92.7K after
Nov 14, 2023 (view filing)Nov 131 dayGiraudo BryanCOO/CFOPPurchase+200.0K$0.56+$112.0K+111.1%380.0K after
Apr 5, 2023 (view filing)Apr 41 dayGiraudo BryanCOO/CFOPPurchase+55.0K$1.02+$56.1K+77.5%126.0K after
Mar 22, 2023 (view filing)Mar 202 daysGiraudo BryanCOO/CFOPPurchase+50.0K$0.97+$48.5K+238.2%71.0K after
Jul 15, 2022 (view filing)Jul 15Same dayGiraudo BryanCOO/CFOPPurchase+13.9K$7.21+$100.0K+194.8%21.0K after
Mar 24, 2022 (view filing)Mar 231 dayGiraudo BryanCOO/CFOSSale−10.7K$8.92−$95.6K−9.8%99.2K after